查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1797971

2032 年婦科機器人手術市場預測：按組件、手術類型、應用、最終用戶和地區進行的全球分析

Gynecology Robotic Surgery Market Forecasts to 2032 - Global Analysis By Component (Robotic Surgical Systems, Instruments & Accessories and Services & Maintenance), Procedure Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球婦科機器人手術市場預計在 2025 年達到 48 億美元，到 2032 年將達到 113 億美元，預測期內的複合年成長率為 12.9%。

婦科機器人手術是一種技術先進的微創手術方法，利用機器人系統輔助執行複雜的婦科手術，提高手術的精確度和控制力。外科醫師透過主機控制機械臂，將手部運動轉化為患者體內精密的器材運動。此技術常用於子宮切除術、子宮肌瘤切除術和子宮內膜異位症治療。其優點包括減少失血、縮小切口、加快恢復速度以及提高手術可視性，使其成為精細、高精度婦科手術的首選。

《機器人手術雜誌》發表的一篇文獻回顧發現，在分析的 838 篇關於婦產科機器人手術的文章中，41.1% 集中在婦科腫瘤，其次是良性婦科腫瘤（21.0%）和泌尿婦科腫瘤（18.6%）。

微創手術日益受到偏好

患者越來越渴望手術能夠實現更小的切口、更少的失血、更少的術後疼痛以及更快的恢復正常活動。機器人系統完美契合這些願望，它為外科醫生提供了更高的靈活性、手術區域的高清3D視覺化以及比傳統腹腔鏡更大的運動範圍。這使得他們能夠以驚人的精確度執行複雜而精細的手術，最終改善病患的預後，縮短住院時間，降低再入院率。

臨床優勢和報銷不確定性

雖然機器人系統與開放性手術相比具有明顯的優勢，但一些研究表明，對於某些手術，機器人手術的患者治療效果與傳統腹腔鏡手術相當。這種不確定性，加上機器人手術顯著更高的成本，使得醫院難以證明其投資的合理性。此外，保險公司的報銷政策並不總是一致或有利的，機器人手術的報銷率通常與費用較低的腹腔鏡手術相同。這種財務差異阻礙因素了醫療機構投資和使用這些先進系統的積極性，從而嚴重抑制了市場成長。

擴展到門診手術中心 (ASC) 和新應用

隨著機器人系統變得越來越緊湊和經濟高效，它們正成為門診病人的可行選擇，為患者提供更便利、通常更經濟實惠的選擇。在輔助生殖中心 (ASC) 執行複雜手術的能力可以增加患者數量，並帶來更方便的患者體驗。新型儀器和軟體的開發正在為治療深部浸潤性子宮內膜異位症、骨盆器官脫垂以及晚期婦科癌症等複雜疾病鋪平道路，而這些疾病此前無法透過機器人干預治療。向新臨床領域的擴展為市場中的公司帶來了重要的創新和成長機會。

監管障礙和冗長的核准流程

像FDA這樣的監管機構需要大量的臨床數據和檢驗，以確保新型機器人系統及相關設備的安全性和有效性。這項嚴格的流程可能會減緩新技術的市場准入，限制競爭，並對創新構成重大障礙。由於開發人員需要進行耗時且昂貴的臨床試驗來證明其設備的優勢，這可能會阻礙中小型公司進入市場，並減緩技術發展的步伐。

COVID-19的影響：

新冠疫情對婦科機器人手術市場產生了雙重影響。在疫情初期，由於醫院資源和人員被重新分配用於救治新冠患者，擇期手術和非必要手術被推遲或取消，市場經歷了大幅下滑。這導致新的機器人系統部署暫時停止，手術量下降，對主要市場參與者的收益造成了不利影響。然而，隨著醫療體系的調整，疫情也凸顯了機器人手術的獨特優勢。

機器人手術系統市場預計將成為預測期內最大的市場

機器人手術系統領域預計將在預測期內佔據最大的市場佔有率，因為它是機器人手術的核心和最重要的組成部分。機器人手術系統是其技術核心，包含先進的可視化、儀器和控制機制，使市場佔有率能夠以無與倫比的精度執行複雜的手術。

預計預測期內，肌瘤摘除領域複合年成長率最高

預計子宮肌瘤切除術領域將在預測期內實現最高成長率，這得益於子宮肌瘤患病率的不斷上升以及機器人輔助子宮肌瘤切除術已被證實的益處。子宮肌瘤是一種常見疾病，影響許多女性，而機器人手術為切除子宮肌瘤提供了一種微創解決方案。機器人系統卓越的靈活性和3D視覺化技術對此類手術尤其有利，使外科醫生能夠精確地消融和切除肌瘤，同時細緻地保留子宮組織。

佔比最大的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於一系列有利的經濟和人口因素。該地區人口數量龐大且老化速度迅速，導致需要手術介入的婦科疾病發生率不斷上升。這項人口結構變化與中國、日本和印度等主要經濟體的顯著經濟成長相吻合，並由此帶來了醫療支出的成長。此外，該地區各國政府正在大力投資醫療基礎設施的現代化，並促進先進醫療技術的採用。

複合年成長率最高的地區：

預計亞太地區將在預測期內實現最高的複合年成長率，這得益於醫療保健投資的增加、患者人數的不斷成長以及技術應用的強勁推動力。亞洲主要國家可支配收入的不斷成長，正推動患者和醫療保健提供者對機器人手術等高階醫療解決方案的投資興趣。該地區也正在成為醫療旅遊的中心，這使得領先的機器人手術系統製造商紛紛在當地設立辦事處和培訓中心，以支持其市場擴張。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球婦科機器人手術市場（按組件）

  • 機器人手術系統
    • 多臂機器人平台
    • 單埠機器人系統
    • 模組化機器人系統
    • 遠端手術系統
    • 混合系統
  • 設備和配件
    • 內視鏡器械
    • 能源設備
    • 相機和視覺化工具
    • 免洗配件
    • 設備追蹤和校準工具
  • 服務和維護
    • 安裝和設定服務
    • 預防性保養
    • 修正性維護
    • 培訓和認證
    • 遠端監控和支援

6. 全球婦科機器人手術市場（依手術類型）

  • 子宮切除術
  • 子宮肌瘤切除術
  • 卵巢
  • 骶骨陰道固定術
  • 子宮內膜異位症切除術
  • 輸卵管吻合術
  • 其他類型的手術

7. 全球婦科機器人手術市場（依應用）

  • 子宮肌瘤
  • 子宮癌
  • 子宮內膜異位症
  • 卵巢囊腫
  • 骨盆器官脫垂
  • 其他用途

8. 全球婦科機器人手術市場（依最終用戶）

  • 醫院和診所
  • 門診手術中心
  • 醫生診所
  • 專科婦科中心
  • 其他最終用戶

9. 全球婦科機器人手術市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要發展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Intuitive Surgical Inc
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc
  • Globus Medical Inc
  • CMR Surgical Ltd
  • Titan Medical Inc
  • Asensus Surgical Inc
  • Smith & Nephew plc
  • Renishaw plc
  • Johnson & Johnson
  • Siemens Healthineers
  • GE Healthcare
  • Olympus Corporation
  • Boston Scientific Corporation
  • Karl Storz SE & Co. KG
  • B. Braun Melsungen AG
  • Medrobotics Corporation
  • TransEnterix Inc
Product Code: SMRC30341

According to Stratistics MRC, the Global Gynecology Robotic Surgery Market is accounted for $4.8 billion in 2025 and is expected to reach $11.3 billion by 2032 growing at a CAGR of 12.9% during the forecast period. Gynecology robotic surgery is a technologically advanced, minimally invasive surgical approach that utilizes robotic systems to assist in performing complex gynecological procedures with enhanced precision and control. Surgeons operate robotic arms via a console, translating hand movements into refined instrument actions within the patient's body. This technique is commonly used for hysterectomies, myomectomies, and endometriosis treatment. It offers benefits such as reduced blood loss, smaller incisions, faster recovery, and improved visualization, making it a preferred option for delicate and high-precision gynecologic interventions

According to a bibliometric study published in the Journal of Robotic Surgery, out of 838 analyzed publications on robotic surgery in obstetrics and gynecology, 41.1% focused on gynecologic oncology, followed by 21.0% on benign gynecology and 18.6% on urogynecology.

Market Dynamics:

Driver:

Growing preference for minimally invasive surgery

Patients are increasingly seeking out surgeries that result in smaller incisions, reduced blood loss, less postoperative pain, and a faster return to normal life. Robotic systems are perfectly aligned with these desires, offering surgeons enhanced dexterity, a high-definition 3D visualization of the surgical field, and a greater range of motion compared to traditional laparoscopy. This allows for the performance of complex and delicate procedures with remarkable precision, which in turn leads to superior patient outcomes, shorter hospital stays, and lower readmission rates.

Restraint:

Uncertainty in clinical superiority and reimbursement

While robotic systems offer clear advantages over open surgery, some studies have shown that for certain procedures, the patient outcomes with robotic surgery are comparable to those achieved with traditional laparoscopy. This uncertainty, combined with the significantly higher costs associated with robotic procedures, can make it difficult for hospitals to justify the investment. Furthermore, reimbursement policies from insurance providers are not always consistent or favorable, often reimbursing robotic procedures at the same rate as less expensive laparoscopic methods. This financial discrepancy creates a disincentive for healthcare facilities to invest in and utilize these advanced systems, acting as a major restraint on market growth.

Opportunity:

Expansion into ambulatory surgical centers (ASCs) & new applications

As robotic systems become more compact and cost-effective, they are becoming a viable option for outpatient settings, which offer a more convenient and often more affordable option for patients. The ability to perform complex procedures in an ASC can lead to increased patient volume and a more streamlined patient experience. The development of new instruments and software is opening doors for treating complex conditions such as deep infiltrating endometriosis, pelvic organ prolapse, and advanced gynecologic cancers, which previously were not ideal for robotic intervention. This expansion into new clinical areas presents a substantial opportunity for market players to innovate and grow.

Threat:

Regulatory hurdles and lengthy approval processes

Regulatory bodies like the FDA require extensive clinical data and validation to ensure the safety and efficacy of new robotic systems and their associated instruments. This rigorous process can be a major impediment to innovation, delaying the market entry of new technologies and limiting competition. The need for manufacturers to conduct time-consuming and expensive clinical trials to demonstrate the benefits of their devices can discourage smaller companies from entering the market and slow down the pace of technological development.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the gynecology robotic surgery market. In the initial phase of the pandemic, the market experienced a significant downturn as elective and non-essential surgeries were postponed or canceled to reallocate hospital resources and personnel to the care of COVID-19 patients. This resulted in a temporary halt in new robotic system installations and a decline in procedure volumes, which negatively affected the revenue of key market players. However, as the healthcare system adapted, the pandemic also highlighted the unique advantages of robotic surgery.

The robotic surgical systems segment is expected to be the largest during the forecast period

The robotic surgical systems segment is expected to account for the largest market share during the forecast period attributed to its position as the central and most critical component of robotic surgery. The initial high cost of acquiring these sophisticated platforms, along with their associated installation expenses, makes them the largest contributor to market value. These systems are the technological core, housing the advanced visualization, instrumentation, and control mechanisms that enable a surgeon to perform complex procedures with unparalleled precision.

The myomectomy segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the myomectomy segment is predicted to witness the highest growth rate driven by the increasing prevalence of uterine fibroids and the proven benefits of robotic-assisted myomectomy. Uterine fibroids are a common condition affecting many women, and robotic surgery offers a minimally invasive solution for their removal. The exceptional dexterity and 3D visualization provided by robotic systems are particularly beneficial for this procedure, enabling surgeons to precisely dissect and remove fibroids while meticulously preserving the uterine tissue.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to a confluence of favorable economic and demographic factors. The region is home to a vast and rapidly aging population, which is leading to an increased incidence of gynecological conditions requiring surgical intervention. This demographic shift is coinciding with significant economic growth and a corresponding rise in healthcare spending across key countries like China, Japan, and India. Additionally, governments in the region are making substantial investments in modernizing their healthcare infrastructure and promoting the adoption of advanced medical technologies.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by a combination of increasing healthcare investments, a growing patient population, and a strong drive for technological adoption. As disposable incomes rise in key Asian economies, there is a greater willingness among both patients and healthcare providers to invest in premium healthcare solutions like robotic surgery. The region is also becoming a hub for medical tourism and a target for leading robotic surgical system manufacturers, who are establishing local offices and training centers to support market expansion.

Key players in the market

Some of the key players in Gynecology Robotic Surgery Market include Intuitive Surgical Inc, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Globus Medical Inc, CMR Surgical Ltd, Titan Medical Inc, Asensus Surgical Inc, Smith & Nephew plc, Renishaw plc, Johnson & Johnson, Siemens Healthineers, GE Healthcare, Olympus Corporation, Boston Scientific Corporation, Karl Storz SE & Co. KG, B. Braun Melsungen AG, Medrobotics Corporation, and TransEnterix Inc.

Key Developments:

In July 2025, Intuitive Surgical, Inc. receives CE mark for Europe. The latest-generation da Vinci 5 secured CE clearance in July 2025, enabling use in adult and pediatric minimally invasive procedures including gynecology across Europe. The system features force-feedback technology, immersive 3D vision, and streamlined surgeon workflow.

In April 2025, Medtronic plc Submits Hugo(TM) robotic-assisted surgery system to FDA for urologic indication. The Hugo(TM) system achieved primary safety and efficacy endpoints in its Expand URO clinical trial, paving the way for broader U.S. regulatory submissions and anticipated gynecology indications.

Components Covered:

  • Robotic Surgical Systems
  • Instruments & Accessories
  • Services & Maintenance

Procedure Types Covered:

  • Hysterectomy
  • Myomectomy
  • Oophorectomy
  • Sacrocolpopexy
  • Endometriosis Resection
  • Tubal Re-anastomosis
  • Other Procedure Types

Applications Covered:

  • Uterine Fibroids
  • Uterine Cancer
  • Endometriosis
  • Ovarian Cysts
  • Pelvic Organ Prolapse
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Physician Offices
  • Specialty Gynecology Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gynecology Robotic Surgery Market, By Component

  • 5.1 Introduction
  • 5.2 Robotic Surgical Systems
    • 5.2.1 Multi-arm Robotic Platforms
    • 5.2.2 Single-port Robotic Systems
    • 5.2.3 Modular Robotic Systems
    • 5.2.4 Telesurgical Systems
    • 5.2.5 Hybrid Systems
  • 5.3 Instruments & Accessories
    • 5.3.1 Endoscopic Instruments
    • 5.3.2 Energy Devices
    • 5.3.3 Camera & Visualization Tools
    • 5.3.4 Disposable Accessories
    • 5.3.5 Instrument Tracking & Calibration Tools
  • 5.4 Services & Maintenance
    • 5.4.1 Installation & Setup Services
    • 5.4.2 Preventive Maintenance
    • 5.4.3 Corrective Maintenance
    • 5.4.4 Training & Certification
    • 5.4.5 Remote Monitoring & Support

6 Global Gynecology Robotic Surgery Market, By Procedure Type

  • 6.1 Introduction
  • 6.2 Hysterectomy
  • 6.3 Myomectomy
  • 6.4 Oophorectomy
  • 6.5 Sacrocolpopexy
  • 6.6 Endometriosis Resection
  • 6.7 Tubal Re-anastomosis
  • 6.8 Other Procedure Types

7 Global Gynecology Robotic Surgery Market, By Application

  • 7.1 Introduction
  • 7.2 Uterine Fibroids
  • 7.3 Uterine Cancer
  • 7.4 Endometriosis
  • 7.5 Ovarian Cysts
  • 7.6 Pelvic Organ Prolapse
  • 7.7 Other Applications

8 Global Gynecology Robotic Surgery Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Physician Offices
  • 8.5 Specialty Gynecology Centers
  • 8.6 Other End Users

9 Global Gynecology Robotic Surgery Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Intuitive Surgical Inc
  • 11.2 Medtronic plc
  • 11.3 Stryker Corporation
  • 11.4 Zimmer Biomet Holdings Inc
  • 11.5 Globus Medical Inc
  • 11.6 CMR Surgical Ltd
  • 11.7 Titan Medical Inc
  • 11.8 Asensus Surgical Inc
  • 11.9 Smith & Nephew plc
  • 11.10 Renishaw plc
  • 11.11 Johnson & Johnson
  • 11.12 Siemens Healthineers
  • 11.13 GE Healthcare
  • 11.14 Olympus Corporation
  • 11.15 Boston Scientific Corporation
  • 11.16 Karl Storz SE & Co. KG
  • 11.17 B. Braun Melsungen AG
  • 11.18 Medrobotics Corporation
  • 11.19 TransEnterix Inc

List of Tables

  • Table 1 Global Gynecology Robotic Surgery Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gynecology Robotic Surgery Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Gynecology Robotic Surgery Market Outlook, By Robotic Surgical Systems (2024-2032) ($MN)
  • Table 4 Global Gynecology Robotic Surgery Market Outlook, By Multi-arm Robotic Platforms (2024-2032) ($MN)
  • Table 5 Global Gynecology Robotic Surgery Market Outlook, By Single-port Robotic Systems (2024-2032) ($MN)
  • Table 6 Global Gynecology Robotic Surgery Market Outlook, By Modular Robotic Systems (2024-2032) ($MN)
  • Table 7 Global Gynecology Robotic Surgery Market Outlook, By Telesurgical Systems (2024-2032) ($MN)
  • Table 8 Global Gynecology Robotic Surgery Market Outlook, By Hybrid Systems (2024-2032) ($MN)
  • Table 9 Global Gynecology Robotic Surgery Market Outlook, By Instruments & Accessories (2024-2032) ($MN)
  • Table 10 Global Gynecology Robotic Surgery Market Outlook, By Endoscopic Instruments (2024-2032) ($MN)
  • Table 11 Global Gynecology Robotic Surgery Market Outlook, By Energy Devices (2024-2032) ($MN)
  • Table 12 Global Gynecology Robotic Surgery Market Outlook, By Camera & Visualization Tools (2024-2032) ($MN)
  • Table 13 Global Gynecology Robotic Surgery Market Outlook, By Disposable Accessories (2024-2032) ($MN)
  • Table 14 Global Gynecology Robotic Surgery Market Outlook, By Instrument Tracking & Calibration Tools (2024-2032) ($MN)
  • Table 15 Global Gynecology Robotic Surgery Market Outlook, By Services & Maintenance (2024-2032) ($MN)
  • Table 16 Global Gynecology Robotic Surgery Market Outlook, By Installation & Setup Services (2024-2032) ($MN)
  • Table 17 Global Gynecology Robotic Surgery Market Outlook, By Preventive Maintenance (2024-2032) ($MN)
  • Table 18 Global Gynecology Robotic Surgery Market Outlook, By Corrective Maintenance (2024-2032) ($MN)
  • Table 19 Global Gynecology Robotic Surgery Market Outlook, By Training & Certification (2024-2032) ($MN)
  • Table 20 Global Gynecology Robotic Surgery Market Outlook, By Remote Monitoring & Support (2024-2032) ($MN)
  • Table 21 Global Gynecology Robotic Surgery Market Outlook, By Procedure Type (2024-2032) ($MN)
  • Table 22 Global Gynecology Robotic Surgery Market Outlook, By Hysterectomy (2024-2032) ($MN)
  • Table 23 Global Gynecology Robotic Surgery Market Outlook, By Myomectomy (2024-2032) ($MN)
  • Table 24 Global Gynecology Robotic Surgery Market Outlook, By Oophorectomy (2024-2032) ($MN)
  • Table 25 Global Gynecology Robotic Surgery Market Outlook, By Sacrocolpopexy (2024-2032) ($MN)
  • Table 26 Global Gynecology Robotic Surgery Market Outlook, By Endometriosis Resection (2024-2032) ($MN)
  • Table 27 Global Gynecology Robotic Surgery Market Outlook, By Tubal Re-anastomosis (2024-2032) ($MN)
  • Table 28 Global Gynecology Robotic Surgery Market Outlook, By Other Procedure Types (2024-2032) ($MN)
  • Table 29 Global Gynecology Robotic Surgery Market Outlook, By Application (2024-2032) ($MN)
  • Table 30 Global Gynecology Robotic Surgery Market Outlook, By Uterine Fibroids (2024-2032) ($MN)
  • Table 31 Global Gynecology Robotic Surgery Market Outlook, By Uterine Cancer (2024-2032) ($MN)
  • Table 32 Global Gynecology Robotic Surgery Market Outlook, By Endometriosis (2024-2032) ($MN)
  • Table 33 Global Gynecology Robotic Surgery Market Outlook, By Ovarian Cysts (2024-2032) ($MN)
  • Table 34 Global Gynecology Robotic Surgery Market Outlook, By Pelvic Organ Prolapse (2024-2032) ($MN)
  • Table 35 Global Gynecology Robotic Surgery Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 36 Global Gynecology Robotic Surgery Market Outlook, By End User (2024-2032) ($MN)
  • Table 37 Global Gynecology Robotic Surgery Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 38 Global Gynecology Robotic Surgery Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 39 Global Gynecology Robotic Surgery Market Outlook, By Physician Offices (2024-2032) ($MN)
  • Table 40 Global Gynecology Robotic Surgery Market Outlook, By Specialty Gynecology Centers (2024-2032) ($MN)
  • Table 41 Global Gynecology Robotic Surgery Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.